Versant Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94K | Buy |
513
+82
| +19% | +$1.11K | ﹤0.01% | 2051 |
|
|
2025
Q1 | $6.84K | Buy |
431
+378
| +713% | +$6K | ﹤0.01% | 1909 |
|
|
2024
Q4 | $652 | Sell |
53
-10
| -16% | -$123 | ﹤0.01% | 2250 |
|
|
2024
Q3 | $763 | Hold |
63
| – | – | ﹤0.01% | 1802 |
|
|
2024
Q2 | $737 | Hold |
63
| – | – | ﹤0.01% | 1730 |
|
|
2024
Q1 | $813 | Hold |
63
| – | – | ﹤0.01% | 1588 |
|
|
2023
Q4 | $542 | Buy |
+63
| New | +$542 | ﹤0.01% | 1659 |
|
|
2023
Q3 | – | Sell |
-32
| Closed | -$546 | – | 2009 |
|
|
2023
Q2 | $546 | Buy |
+32
| New | +$546 | ﹤0.01% | 1814 |
|